bioAffinity Technologies, Inc. Common Stock BIAF

$10.45 +58.60% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-01 View →
S-3 S-3 2026-08-27 View →
8-K 8-K 2026-08-20 View →
8-K 8-K 2026-08-18 View →
8-K 8-K 2026-08-14 View →
10-Q 10-Q 2026-08-07 View →
8-K 8-K 2026-08-07 View →
8-K 8-K 2026-07-31 View →
8-K 8-K 2026-07-27 View →
8-K 8-K 2026-07-22 View →
8-K 8-K 2026-07-07 View →
8-K 8-K 2026-06-30 View →
8-K 8-K 2026-06-18 View →
8-K 8-K 2026-06-16 View →
S-1 S-1 2026-06-12 View →
8-K 8-K 2026-06-02 View →
8-K 8-K 2026-05-27 View →
8-K 8-K 2026-05-12 View →
10-Q 10-Q 2026-05-11 View →
8-K 8-K 2026-05-08 View →
S-1 S-1 2026-04-30 View →
8-K 8-K 2026-04-30 View →
8-K 8-K 2026-04-14 View →
8-K 8-K 2026-04-07 View →
8-K 8-K 2026-04-01 View →
8-K 8-K 2026-03-26 View →
8-K 8-K 2026-03-25 View →
8-K 8-K 2026-03-17 View →
DEF 14A DEF 14A 2026-03-16 View →
10-K 10-K 2026-03-16 View →
8-K 8-K 2026-03-13 View →
8-K 8-K 2026-03-10 View →
8-K 8-K 2026-03-06 View →
8-K 8-K 2026-03-03 View →
8-K 8-K 2026-02-25 View →
8-K 8-K 2026-02-19 View →
8-K 8-K 2026-02-17 View →
8-K 8-K 2026-02-10 View →
8-K 8-K 2026-02-09 View →
8-K 8-K 2026-02-04 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$10.45
Market Cap
$3.90 million
52-Week Range
$4.56 – $202.50
Average Volume
3.42 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.